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Iranian J Parasitol: Vol.  5 , No. 3 , 20 10 , pp .   48 - 56     48                   Original Article     The Effect of Vitamin D3 Alone and Mixed With  IFN - γ   on Tach y - zoites of  Toxoplasma gondii  (RH Strain) Proliferation and Nitric Ox - ide (NO) Production in Infected Macrophages of BALB/C Mice         * F Ghaffarifar 1  ,  M  Abdolah Pour 1 ,   Z  Sharifi  2  ,      A  Dalimi Asl  1 , E Al - Kawaz 3     1  Department of Parasitology,  Tarbiat Modarres University, Tehran , Iran   2  Organization of Blood Transfusion, Research Center of Virology,  Tehran , Iran   3  Department of Public Health, College of Medical and Hea lth Technology, Baghdad, Iraq     (Received 10  Oct  2009; accepted 17  May  2010)       Abstract     Introduction:  Toxoplasma gondii  is an obligatory interacelullar parasite that infects nucleated  cells in its interm e diate hosts. The aim of the present study was to det ermine the effect of vitamin  D3 on the multiplication of  T. gondii  in peritoneal macrophage of B alb/c  mice and nitric oxide  production by macrophages.     Methods:  According to  usage of  vitamin D3 (one dose or seven doses) and INFγ in vitro and in  vivo, this  study was divided into four experiments. In all experiments, the macrophages were co l - lected from peritoneum and cultured in RPMI - 1640. Then the supernatants were collected after  24 h and  their nitric oxide was measure. After  96 h, the macrophages were co llected and stained   and  the number of tachyzoites was measured.     Results:  The first experiment (the mice were infected with tachyzoites and after 2 h, got one dose   vita min D3 intr a peritonealy) showed the best results. The mean of tachyzoites per macropha ges  was 2.37, and mean ± SD of nitric oxide was 187.8 ± 9.    Discussion:  High - level production of nitric oxide may be related to the only one injection of vita - min D3. The inje c tion in long time might suppress the immune system.      Keywords:  Toxoplasma gondi i , Vitamin D3, Nitric Oxide, IFN - γ, Macrophages, Mice         Introduction               Iranian Society of Parasito l ogy   http:// isp.tums.ac.ir     Iranian J Parasitol     Open access Journal at   http:// ijpa.tums.ac.ir       Tehran University of Med i cal  Sciences Public a tion   http:// tums.ac.ir       * Corresponding author :  Fax ,++98 - 21 -  82884555,     E - mail : ghafarif@modares.ac.ir       Ghaffarifar et al.:The Effect of Vitamin D3…     49     Introduction       oxoplasma  gondii   is  an  obligatory  intrace l lu lar  protozoan  parasite  that  infects  all  mammalian  cells.  Human  infection is gener ally asymptomatic and self - limiting  in   immunocompetent  hosts.  The  parasites  are  encysted  in  the  brain  and  muscle  and  the  in fected  individuals  chronically  deve l op  life - long  protective  immunity  against  reinfection  (1,  2).  In  contrast,  in  immunocompromised  individuals, toxoplasmosis represents o ne of  the major opportunistic infections (3, 4). It is  most often due to reactivation of the latent  infection and may result in toxoplasmic e n - ce phalitis (3, 4).   Inducing synthesis of ni tric  oxide  (NO)  is  an  important  microbicidal  mechanis m  of  IFN - γ  activated  murine  macr o phages  to  restrict  interacelullar  replica tion of  T. gondii  (5, 6). Inhibition of  NO production in mice could led to progres - sive  toxoplasmic  encephalitis  and  chronic  ocular toxoplasm o sis (7, 8).   The role of vitamin D in t he regulation of  calcium (Ca) and phosphorus metabolism is  well - established (9). There are noncalcemic  roles of vitamin D, including its role in the  immune  sy s tem  (10).  Receptors  for  1,25 - dihy droxy  vitamin  D3    (VDR)  have  been  found in human peripheral blo od monocytes  and in the active lymphocytes of both rat and  human (11 - 12). In addition to  in vitro  act i - vated lymphocytes,  in vivo  expression of the  VDR  occurs  in  peripheral  blood  lymph o - cytes of rheumatoid arthritis patients (13), in  alveolar lymphocytes f rom the patients with  pulmonary  granuloma  diseases  such  as  sa r coi dosis  and  tuberculosis  (14).  On  the  other  hand,  decreased  concentrations  of  VDR are found in peripheral blood mononu - c lear cells in the patients with x - linked hypo - phosphatemic  rickets  (15) .  Fu r thermore,  1,25 - (OH)2D3  exerts  an  antiprolifer ative  action on peripheral blood mononuclear cells  (16)  and  decreases  interleu kin - 2  (IL - 2)  produ c tion  by  phytohe maglutinin  activated  human peripheral mono nuclear cells (17). A  major advance o c curred w ith this demonstra - tion  that  1,  25 - (OH)2D3  can  prevent  or  mark edly  suppress  such  autoimmune  dis - eases  as  exp e rimental  autoimmune  encephalo myelitis  (18,19),  expe rimental  arthri tis in mice (20), and Type I diabetes in  NOD  mice  (21).  Further,  1,  25 - (OH)  2 D3  can  prolong  transplanted  allograft  survival  equal  to  or  sup e rior  to  cyclosporin  (22),  dem onstrating  the  importance  of  1,25 - (OH)2D3  in  the  immune  system.  1,25 - (OH)2D3 appears to function largely, if not  excl u sively,  through  a  nuclear  receptor  (VDR) (23) , which is a member of the ste - roid/thyroid  hormoneactivated  tra n scription  factor family and is believed to act via bind - ing as a heterodimer to vit a min D - responsive  elements  found  in  the  promoter  of  target  genes (24). Although nongenomic actions of  1,25 - ( OH)2D3 have been championed (25),  so far its physiologic signifi c ance  remains  to be established. The results of a survey by  Rokett   et  al.  showed  that  1,  25  dihydroxy  vitamin D3 may increase pr o duction of nitric  oxide (26).     In  some  groups  of African and  Americans,  has been observed that low levels of the a c - tive form of vitamin D3 that often occur in  this population correlate with increased su s - ceptibility to infection. Vitamin D3 may   be  related in the immune response to tubercul o - sis too. 1,25(OH)2D3  is   known to increase  the phagocytic potential of macrophages   in - fected with live  Mycobacterium tubercul o sis   in normal healthy subjects and decrease the  lymphoproliferative  response  in  pulmonary  tube r culosis patients (27).   The present study was conducted to  evaluate  the effect of vitamin D3 and IFN - γ alone or  T  Iranian J Parasitol: Vol.  5 , No. 3 , 20 10 , pp .   48 - 56     50   in  combination  on  the  growth  rate  and  repl i ca tion of  T. gondii  in macrophages.     Materials and Methods     Parasites   Tachyzoites  of  T.  gondii  (RH  strain)  were  injected  intraperitonealy  in  the  mice.  The  mic e were killed after 3 days and the tach y - zoites were collected from their peritoneum.     Animals   We  used  84  inbred  female  mice  ( B alb/c )  with the age of 6 - 8 weeks and the weight of  18 - 20g. The mice were divided into four e x - pe riments and each experiment cons isted of  seven  groups  of  mice  (three  mice  in  each  group).     Vitamin D3 and  IFN - γ     We  obtained  the  materials  from  Sigma  C hemi cal Co. Ethanol 95% was applied as a  solvent  for  vitamin  D3.  Evalu a tion  of  the  effect of vitamin D3 and IFN - γ on the prol i f - e ration of  T. gondii  and NO production by  the infected m a crophages was performed  in  four separated experiments including:   In the first experiment, vitamin D3 and 1.0  ×10 6   T. gondii  tachyzoites were  intraperito - nealy   i n jected  24  hrs  before  macrophages  collection in the mice, (the interval between  vitamin D3 and tachyzoites injection was  2  h).   In  the second  experiment,  vitamin  D3  was   intraperitonealy  injected for one week (every  day for seven days),and then  infected by1.0  ×10 6   T. gondii  tachyzoites (the interval be - tween the last i n jection of vitamin D3 and  tachyzoites  injection  was  2  h) .  In  both  experi ments, 24 h after tach y zoites injection,  the macrophages were collected and cultured  in  triplicate  in  24 - well  cell  culture  plates  (Nunc) (2 × 10 6  macrophages/well).     In the third experiment,    the mice were i n - fected  by  1.0  ×10 6    T.  gondii   tachyzoites.  The infected macrophages were collected 24  h after and cultured in triplicate in 24 - well  cell  culture  plates  (Nunc)  (2  ×  10 6  macr o - phages/well).  Then vitamins D3 were added  to the macrophage culture.    In  the  fourth  experiment,  vitamin  D3  was   intraperitonealy injected to the mice, the m a - crophages   separated from the peritoneum  24h after and cultured in 24 - well cell culture  plates (2 × 10 6  m a crophages/well). Then1.0  ×10 6   T.  gondii   tachyzoites  were  added  to  cultured macrophages.       Grouping for  each experiment     Each experiment consisted of seven groups  of mice.   1 - First control group, the macrophages were  infected with 1.0 ×10 6    T. gondii  tachyzoites.   2 -   Second  control  group,  the  macrophages  were infected with 1.0 ×10 6    T. gondii  tach y - zoites an d  ethanol was  added the as the sol - vent of vitamin D3.   3 -  The group that before infection with 1.0  ×10 6     T. gondii  tachyzoites got the vitamin  D3, and then IFN - γ added to cultured m a cro - phages.    4 -  The group that before infection with 1.0  ×10 6     T. gondii  tachyzoites got the vitamin  D3, wit h out the addition of IFN - γ.   5 -  The group that infected with 1.0 ×10 6  T.  gondii  tachyzoites, then IFN - γ added to cul - tured m a crophages without vitamin D3.   6 - The group that infected with 1.0 ×10 6    T.  gondii   tachyzoites,  th en  NMMA  ( N G - me - thyl - l - arginine) 1mM was added (as neg a tive  control).   7 -  The group that infected with 1.0 ×10 6  T.  gondii   tachyzoites,  then  SNAP  ( S - nitroso - acetylpenicillamin)  1mM  was  added  (as  po s i tive control).       Nitric Oxide  (NO ) measurement   In aqueous s olution, nitric oxide rapidly de - grades to nitrate and nitrite, for Spectroph o - to metric quantitation of nitrite using Griess  Reagent is sensitive.  Ghaffarifar et al.:The Effect of Vitamin D3…     51       Griess reagent   Griess  reagent  contain s   of  two  solution,  sulfa ni lamide solution and naphthylethylen e - diam ine  dihydrochloride  solution  that  pre - pared  separately,  stored  at  4°C,  and  pr o - tected from light. The Griess reagent is mix  of  1  part  0.1%  naphthylethylenediamine  d i hy drochloride in distilled water plus 1 part  1% sulfanilamide in 5%  H 3 PO 4 .   For NO measure ment, the supernatants were  collected daily and compared with eight ni - trite sta n dard concentrations (0 to 35  µ M ).  For nitrite standard, we prepared sodium n i - trite  NaNO 2   (MW=69)  1000   µ M  as  stock  solution,  then  prepared  8  standards  conce n tra tion (0, 5, 10, 15, 20, 25, 30 and 35   µ M).   One hundred  µ l of each of the standards and  the  samples  (supernatants  of  the  cel l  cu l - tures) was added into the wells of a 96 - well  plate in duplicates. Then, 100  µ l of Griess  reagent was added to each well and the plate  was  incubated  at  room  temperature  for  10  min. The absorbance was read at 550 nm on  a plate reader (28).     Statistical  analysis   For analysis of the differences between the  mean of parasites in  macrophages and NO  production  among  the  different  groups  An o va - oneway test was used.     Results     The  results  indicated  that  vitamin  D3  could  affect  T.  gondii   proliferation  and  NO prod uction by infected macr o phages.  The  best  results  for  the  inhibition  of  t a chy zoites proliferation were obtained in  the fourth and the first e x periments using  IFN -   γ (100 IU) and  vitamin D3 (1000 IU)  (2.03 ±0.1875, 2.37 ±   0.1901  tachyzoites  per macr o phages respectively ) and the dif - ference with the control group was signifi - cant.  For NO production by the i n fected    macrophages,  the  best  results  were  ob - tained  in  the  sa me  groups  (191.5±9.62,  187.8  ± 0.9821 , respectively ). The results  for other groups are shown in Table 1 and  2.      In the second experiment, the effect of us - ing  vitamin D3(1000 IU) had no signifi - cant diffe r ences with the control groups,  but  using  IFN -   γ(10 0  IU)  and  vitamin  D3(1000 IU) or IFN -   γ(100 IU),  showed  significant  differences  with  the  control  groups  ( P <0.05).   For NO production  by the infected m a cro - phages,   in  the  second  experiment,  there  were signif i cant differences among groups  with IFN -   γ(100 IU)  and  IFN -   γ(100 IU)  plus  vitamin  D3(1000  IU)  with  control  groups  ( P <0.05). In this experiment, there  was not any significant differences among  vitamin  D3  group  (1000 IU) with control  groups  ( P >0.05).   The  results  for  NMMA  in  group  6,  and  SNAP in group 7 was  approximately the  same in both nitric oxide produ c tion and  ta chyzoites  proliferation  in  four  exper i - ments.                  Iranian J Parasitol: Vol.  5 , No. 3 , 20 10 , pp .   48 - 56     52     Table 1:  Mean  ±  SD of  tachyzoites per macrophages after 96 h of culture in cell culture media            Groups       Experiments   Control   Grou p1   Mean  ± SD   Solvent   (ethanol  95)   Group2   Mean  ± SD   IFN -   γ (100 IU)   & Vitamin  D3(1000 IU)   Group3   Mean  ±  SD   Vitamin  D3(1000 IU)   Group4   Mean  ±  SD   IFN -   γ(100  IU)   Group5   Mean  ±  SD   First    3.01 ± o.14     2.93 ±0.16      *2.37 ±   0.19    *2.49 ±     0.19     *2.6   ±    0.2      Second     3.15  ±  0.12    3.03 ±0.16     *2.58  ±  0.13       2.74 ±0.16    *2.5 ±0.15     Third     3.05 ±  0.15       3.04  ±0.14      *2.69 ±  0.2      2.82    ±     0.17     *2.57  ± 0.16      Fourth       3.16  ±  0.14     3  ±  0.14     *2.03 ±   0.19     *2.39  ±    0.19     *2.59 ±   0.2       SD= standard deviation   INF - γ= interferon gamma   IU= International Unit    *  Si gnifican differences   P    ≤ 0.05       Table 2:  Mean  ±  SD of  nitrite  (µM /ml) produced by macrophages after 24 h of culture in cell  culture media       SD= standard deviation   INF - γ= interferon gamma   IU= International Unit   * S ignificant  differences    P   ≤ 0.05               Groups       Experiments   Control   Group1     Mean  ±  SD   Solvent    (ethanol 95)   Group2   Mean  ± SD   IFN -   γ (100  IU)   & Vitami n  D3(1000 IU)   Group3   Mean  ±  SD   Vitamin  D3(1000  IU)   Group4   Mean  ±  SD   IFN -   γ(100  IU)   Group5   Mean  ±  SD   First       109 ± 8.02     108.2±12.45       *187.8±9.82      *165±    11.30     *146  ±  7.22     Second       108± 9.46      108.9 ±6.93     *136.2±10.21     121.2 ±6.68    *139 .5  ±5.76     Third        109.6 ±7.35      108.2± 4.96     *146.9 ± 9.62    *139 ± 7.01       *146  ±  4.93      Fourth        109±   7.03   108.6 ± 4.26    *191.5 ± 9.62     *166 ± 7.01      *146.2  ±  5.60  Ghaffarifar et al.:The Effect of Vitamin D3…     53     Discussion     Epidemiological studies have linked vitamin  D deficiency to   increased rates of cancer, as  well as autoimmune and infectious   diseases  (29).   Insufficient  vitamin  D  is  related  to  some  infec tious  disease  such  as  tuberculosis.  Asso ci ations b e tween vitamin D deficiency  and TB susceptibility   were described over 20  years ago (30 , 31 ).    The activated form of vitamin D on calcium  and bone metabolism has been described. In  vitro, but also in vivo, 1,25(OH) 2 D 3  has po - tent  effects  on  cell  proliferation  and  cell  di f fe r entiation  in normal cell types as well  as  in  malignant  cell  types.  Receptors  for  1,25(OH) 2 D 3   have  been  found  in  different  immune cells such as the cells of the mon o - cyte to macrophage lineage, (32) acti vated T  and  B  lymphocytes.  In  vitro,  clear  effects  can  be  seen,  including  the  induction  of  mono cyte  di f ferentiation  and  the  inhibition  of  antigen  presentation  by  antigen - present - ing  cells,  inhib i tion  of  T - cell  proliferation  and  cytokine  production,  and  inhibition  of  sec r e tion of antibodies by B - cells. These in  vitro effects are reflected in vivo by a poten - tial  to  prevent  autoimmune  diseases  in  di f fer ent  experimental  models,  and  to  pro - long graft survival (33 - 34).   A  major  problem  with  the  in  vivo   use  of  1,25(OH) 2 D 3   is  t he  fact  that  the  doses  needed to see non - classical effect such as the  immune effects  are high, resulting in severe  hypercalcaemia  and  accelerated  bone  r e mode l ing. Due to the flexible structure of  1,25(OH) 2 D 3 ,  however,  chemists  have  suc - ceeded  in  synthes ising  analogues  of  the  mole cule, some of which share the mother  m o lecules’  effects  on  the  immune  system,  but  not  its  effects  on  calcium  or  bone  metabo l ism  (35 - 36).   In the previous study we were found that in  the  wells  treated  with  IFN - γ,  replication  ra tes  of  T.  gondii   were  decreased  signifi - can t ly  72h  post  inoculation  in  comparison  with control group ( P <0.05). There was no  significant  di f ference  among  different  groups in NO production (37).     In this study, the results in the first exper i - ment showed tha t vitamin D3 had strong ef - fect  on  the  inhibition  of  tachyzoites  prolif e ra tion and on the increase of NO pro - duction, and that the effect of this vitamin  was  more  than  IFN -   γ.  When  IFN -   γ  was  added to this vitamin, it showed potent ef - fects  on  the  i n hibition  of  tachyzoites  prolifera tion and on the increase of NO pro - duction. The r e sults also showed that the use  of IFN -   γ and vit a min D3 can reinforcement  each other.    In the s econd experiment , the effect of us - ing  vitamin D3(1000 IU) had no signifi cant  diffe r ences with the control groups, but us - ing  IFN -   γ(100  IU)  and  vitamin  D3(1000  IU)  plus  IFN -   γ(100  IU)    had  sig nificant  differ ences with the control groups  ( P <0.05).  In t his experiment, the  vi tamin D3 did not  have  any considerable ef fect on the inhibi - tion of tachyzoites prolife ration and NO pro - duction and the di f ferences were not signifi - cant.  In  the  group  that  used  vitamin  D3  (1000  IU)  plus  IFN -   γ(100  IU),  the  effec t   was  related  more  to  IFN -   γ and no  to  the  vita min D3. In this experiment ,  the results  showed that when vitamin D3 was added to  macro phage culture (in - vitro),  could  less be  The authors declare that they have no con - flicts of interest. - verted to the effe ctive form  (1,25(OH) 2 D 3 ).  1,25 - dihydroxy - cholecalcif - e rol is the most p o wer ful metabolite of vita - min D3 and the highest effect of vitamin D3  is related to this metabolite.     Iranian J Parasitol: Vol.  5 , No. 3 , 20 10 , pp .   48 - 56     54   In the third  experiment , where the mice got  vitamin D3 (1000 IU) for one week,  the e f - fect on the inhibition of  T. gondii  tachyzoites  and NO production was less than in the first  experiment which vitamin D3 was used only  once.  These results  indicated that the inje c - tion  of vitamin D3  every day for one week  might have more suppressiv e effect on the  immune system.   In  the  fourth  experiment,   the  results  were  better  than  in  other  experiments  and  ind i - cated that   the injection of vitamin D3,  24 h  before adding  T. gondii  was more effective  than other exper i ments.   The probable reason of di fferences between  the four experiments could be the influence  of  1 -   α  hydroxylaze  in  vivo   that  affected  vita min  D3  and  changed  it  into  activated  form of 1,25 dih y droxy vitamin D3. When  vitamin D3 was added in vitro, it was less  changed      into  its  activated  form  of  1,25  d i hy droxy vitamin D3 because there was not  any 1 -  α hydroxylaze enzyme  in vitro  cond i - tion.   In  conclusion,  the  results  indicated  that,  high - level production of nitric oxide might  be related to one injection of vitamin D3 in  the first and fourth  experiment s.     A cknowledgements     This study was supported by Tarbiat Mo d - arres University research grant.  The authors  wish to thank Miss Ghasemi for kind hel p - ing. The authors declare that they have no  conflicts of interest.      References     1 .   Remington  JS,  Desmonts  G.  Toxopl asm o sis. In: Infectious Dis eases of  the  Fetus  and  Newborn  In fant.  J  S  Reming ton JOW B Klein, ed. Saunders,  Philadelphia, 1983.    2 .   McCabe R, Remington JS. Toxoplas m o - sis: the time has come. N Engl J Med.  1988; 313:318.   3 .   Luft BJ, Remington JS. AIDS com me n - tary: toxoplasmic encephalitis in AIDS.  Clin Infect Dis. 1992; 15:211.   4 .   Israelski  DM,  Remington  JS.  Toxopla - s mo sis in patients with can cer. Clin Infect  Dis. 1993;17 ( l):S423.   5 .   Adams  LB,  Hibbs  JB,  Taintor  RR,  Kr a hen buhl JL. Microbiostatic ef fect of  mu r ine - activated  macro phages  for  Toxoplasma go n dii . Role for synthesis of  in organic nitro gen ox ides from L - argin - ine. J Immunol. 1990; 144: 2725 – 2729.   6 .   Yap GS, Sher A. Effector cells of both  non - hemopoietic and hemopoi etic origin  are required for interfer on (IFN) - g -  and  tu mour necrosis factor (TNF) - a - depend - ent  host  resis tance  to  the  intracellular  patho gen,  Toxo p lasma  gondii .  J  Exp  Med. 1999; 189: 1083 – 1091.   7 .   Roberts  F,  Roberts  CW,  Ferguson  DJ,  McLeod  R.  Inhibtion  of  nitric  oxide  produ c tion  exacerbates   chronic  ocu lar  toxoplasm o sis. Parasite Immunol. 2000;   22:1 – 5.   8 .   Schlu¨ ter D, Deckert - Schlu¨ ter M, L o - renz E, Meyer T, Ro¨llinghoff M, Bog - dan C. Inhibition of inducible ni tric oxide  synthase  exacerbates  chronic  cerebral  toxoplasmosis  in  Toxoplasma   gon dii - suscep tible C57BL/6 mice but does not  re acti vate the latent di s ease in T. gondii - re sistant  BALB/c  mice.  J  Immu nol.  1999; 162:3512 – 3518.   9 .   DeLuca  HF,  Schnoes  HM.  Metabo lism  and mechanism of action of vita min D.  Annu Rev Bi o chem. 1976; 52:411 – 439.   10 .   Lemire  JM.  Immunomodulatory  ac tions  of  1,25 - dihydroxyvitamin  D3.  J  Steroid  Bi o chem  Mol  Biol.  1995;  53(1 - 6):599 – 602.    11 .   Manolagas SC, Provvedini DM, Tso u kas  CD.  Interactions  of  1,25 - dihy droxyvita -Ghaffarifar et al.:The Effect of Vitamin D3…     55   min  D3  and  the  im mune  sy s tem.  Deol  Cell Endocrinol. 1985;  43:113 – 122.   12 .   Yu  XP,  Mocharla  H,  Hustmyer  FG,  M a no lagas  SC.  Vitamin  D  receptor  ex - pres sion in human lymphocytes. Sig nal re - quire ments and characteriza tion by west - ern  blots  and  DNA  sequencing.  J  Biol  Chem. 1991; 266:7588 – 7595.   13 .   Manolagas SC, Provvedini D M, Murray  EJ,  Tsoukas  CD,  Deftos  LJ.    The  antiprol i f era tive effect of calcit riol on hu - man per i pheral blood mono nuclear cells. J  Lab Clin Med.   1986;   63(2):394 – 400.    14 .   Biyoudi - Vouenze R, Cadrand J, Valeyre  D, Milleron B, Hance A, Soler P.  Expre s - sion of  1,25(OH)2D3 receptors on alveo - lar lymphocytes from patients with pulmo - nary  granulo matous  diseases.  Am  Rev  Res pir Dis. 1991; 143:1376 – 1380.   15 .   Nakajima S, Yamada K,  Yamamoto T,  Okada S, Tanaka H, Seino Y. IL 3 and IL  6 do not induce bone resorp tion in vit ro.  Bone Miner. 1990; 10:201 – 209.   16 .   Manolagas SC, Provvedini DM, Murray  EJ, Tsoukas CD, Deftos LJ. .Association  be tween  the  expression  of  the  c - myc  onco gene mRNA and the expression of  the  rece p tor  protein  for  1,25 - dihydroxyvita min  D3.J  Clin  Endocrinol  Me tab. 1986; 63:394 – 400.   17 .   Tsoukas CD, Provvedini DM, Manol a gas  SC.  1,25 - dihydroxyvita min  D3:  a  novel  im munoregulatory  hormone.  Science.  1984; 224:1438 – 1441.   18 .   Lemire  JM,  Archer  DC.  1,25 - dihy - droxyvi tamin  D3  prevents  the  in  vivo  induc tion of murine experime ntal autoi m - mune  encephalomyelitis.  J  Clin  Invest.  1991;  87:1103 – 1107.   19 .     Cantorna  MT,  Hayes  CI,  DeLuca  HF.  1,25 - Dihydroxyvitamin  D3  reversi bly  blocks  the  progression  of  re lapsing  encepha lomyel i tis,  a  model  of  multiple  scle rosis. Proc Natl Acad Sci. US A. 1996;   93:7861 – 7864.   20 .     Cantorna  MT,  Woodward  WD,  Hayes  CE, DeLuca HF. 1,25 - Dihy droxyvitamin  D 3  is a pos i tive regula tor for the two anti - en cepha litogenic  cytokines  TGF - ß1  and  IL - 4. J  Immu nol .  1998; 160:5314 - 5319.   21 .     Mathieu C, Waer M, Casteels K, Lau reys  J, Bouillon R.   Prevention of type I d i abe - tes  in  NOD  mice  by  non hypercalcemic  doses of a new struc tural analog of 1,25 - dihy droxyvita min  D 3 ,  KH1060.  Endo - crino l ogy. 1995; 136: 866 – 872.   22 .     Hullett  DA,  Cantorna  MT,  Redaelli  C,  Humpal - Winter  J,  Hayes  CE,  Sollin ger  HW, DeLuca HF. Prolonga tion ofallograft  sur vival  by  1,  25 - dihydroxyvitamin  D3.  Tran s plan tation. 1998; 66:824 – 828.   23 .     DeLuca HF. The vitamin D story: a co l la - borative effort of basic science and clini cal  med i cine. FASEB J. 1988;  2(3):224 – 236.   24 .     Darwish HM, DeLuca HF.  Vitamin D - regulated gene expression. Crit. Rev. Eu - k a ryo tic  Gene  Expression.  1993;  3:89 – 116.   25 .     Zanello LP, Norman AW. Rapid mo d ula - tion of osteoblast ion channel re s ponses by  1_ ,  25 (OH)2 - vitamin  D3  requires  the  pres ence of  a func tional vitamin D nuc lear  re ceptor. PNAS. February 10, 2004; 101(  6):1589 – 1594.   26 .     Rokett KA, Brookes R, Udalove I.  1,25 - Dihydroxy vitamin D3 induces ni tric ox - ide  syntheses  and  suppresses  growth  of  My cobac terium tuberculo sis in a human  ma cr o p hage - link  cell  line.  J  Inf  Immu - nity.1998;  66:5314 - 5321.   27 .     Prabhu Anand S, Selvaraj P, Naraya nan  PR. Effect of 1,25 dihy droxyvitamin D3  on intrace l lular IFN - c and TNF - a positive  T cell sub sets in pulmonary tuberculosis.  Cyto kine. 2008; 43:26 - 33.   28 .     Seabr a SH, DeSouza W, DaMatta RA.  Toxoplasma gondii  partially inhib its nitric  oxide  production  of  acti vated  murine  macr o phage.  Exp  Parasitol.  2002;  100(1):62 - 70.  Iranian J Parasitol: Vol.  5 , No. 3 , 20 10 , pp .   48 - 56     56   29 .     Schwalfenberg G.  Not enough vita min D  for Canadians. Can Fam Physi cian. 2007;  53:841 - 854.   30 .     D avies PDO, Brown RC, Woodhead JS.  Serum concentrations of vitamin D meta - bo lites in untreated tuberc u lo sis. Tho rax.  1985; 40:187 - 190.   31 .     De la Torre MS, Torres C, Nieto G, Ver - gara S, Carrero AS, Macia J, Pineda JA,  Ca ruz A, Fibla J. Vitamin D receptor g ene  ha p lo types  and  suscep tibility  to  HIV - 1  infec tion in in jection drug users. J Infect   Dis. 2008; 197:405 - 410.   32 .     Veldman CM, Cantorna  MT,  DeLuca  HF. Expression of 1,25 - dihy droxyvitamin  D(3) rece p tor in the immune system. Arch  Biochem Biophys. 2000; 3 74, 334 – 338.   33 .     Mathieu C, Adorini L. The coming of age  of 1,25 - dihydroxyvitamin  D 3  analogs  as  im mun o modulatory  agents.  Trend    Mol  Med. 2002; 8:174 – 179.   34 .   Casteels K, Bouillon R, Waer M, M a thieu  C.  Immunomodulatory  ef fects  of  1,25(OH) 2 D 3 .  Curr  Opin  Nephrol  Hy.  1995; 4:313 – 318.   35 .   Bouillon R, Verstuyf AM, Verlinden L,  Branisteanu D, Mathieu C, Van - Baelen H.  Non - hypercalcemic  pharma cological  as - pects  of  vitamin  D  analogs.  Biochem  Phar macol. 1995; 50:577 – 583.   36 .   Verstuyf A, Segaert S, Verlinden L, Bouil - lon R,  Mat hieu C. Recent develo p ments  in the use of vitamin D analogues. Ex pert  Opin Inv Drug. 2000; 9:443 – 455.   37 .     Ghaffarifar F,  Dalimi Asl A,  Sharifi Z,  Ghasemi    S,  Solhjoo    K,  Roodbar  Moham madi  S.    The  Effect  of  Be - t a methasone and IFN - γ  on Repli cation of  Tox oplasma gondii  (RH Strain) and Nitric  Oxide Produc tion in HeLa Cell Culture.  Iran J Al lergy Asthm.   2006; 5(2): 75 - 78.    